Results for tag: "Ublituximab"

Ublituximab is a monoclonal antibody used to treat multiple sclerosis (MS) and other central nervous system (CNS) diseases. It is a type of immunomodulatory drug, which works by targeting a specific protein on the surface of certain immune cells. This protein, CD20, is found on the surface of B cells, which are a type of white blood cell involved in the body's immune response. By targeting CD20, ublituximab can reduce the number of B cells in the body, which can help reduce inflammation and other symptoms associated with MS and other CNS diseases. Ublituximab is currently approved for use in the United States and Europe for the treatment of relapsing forms of MS. It is also being studied for use in other CNS diseases, such as neuromyelitis optica spectrum disorder (NMOSD). Companies in the ublituximab market include Genentech, Biogen, and Roche. Show Less Read more